KyoungJin Lee

Statistics

Publications

Citations

116

H-Index

Active since

2018

Affiliations

Edison Pharmaceuticals (United States)(Current)

KyoungJin Lee is an author at Edison Pharmaceuticals (United States) specializing in estrogen pharmacology, cancer pharmacology, and hormonal therapy.

Publications per year

2018–2018

Publications

Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927

Mehmet Kahraman, Steven P. Govek, Johnny Nagasawa et al. · ACS Medicinal Chemistry Letters · 2018 · 76 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer

Johnny Nagasawa, Steven P. Govek, Mehmet Kahraman et al. · Journal of Medicinal Chemistry · 2018 · 40 citations · Full text

Medicine, Oncology, Pharmacology +14

1–2 of 2